To optimize surgical outcomes, we are investigating how combining surgery with molecular therapies can improve vision. We are investigating proteomics analysis of eye fluids to improve diagnostics and personalized therapies. Combining surgery with the injections of specific molecules can improve surgical outcomes. Our surgeon and scientist teams are involved in developing gene therapies to fix faulty genes, optimzing cell transplants to replace unhealthy tissue, and using proteomic analyses of liquid biopsies to select the personalized drugs in hard to treat cases.
In addtion, we apply evidence-based approaches to study and improve traditional surgery for our patients. We also translate human surgical methods into laboratory models of disease.
In all of these endeavors, our educational mission at Stanford continues to foucs on providing the best possible training for surgeons and researchers in advanced surgical techniques. .